Nitroprusside Sodium

Developed for: ST-elevation myocardial infarction
Investigated by: Anyang Regional Hospital · Chinese Academy of Medical Sciences, Fuwai Hospital · First Affiliated Hospital of Xinjiang Medical University · Huaihe Hospital of Henan University · Jincheng People's Hospital · Kaifeng Central Hospital
+22 more
· Lushan People's Hospital · Nanyang Central Hospital · People's Hospital of Zhengzhou University · Puyang Oilfield General Hospital · Puyang People's Hospital · Shenma Medical Group General Hospital · The 99th Central Hospital of the People's Liberation Army · The First Affiliated Hospital of Henan University of Science and Technology · The First Affiliated Hospital of Zhengzhou University · The First People's Hospital of Shangqiu · The First People's Hospital of Xinmi · The First People's Hospital of Zhumadian · The Peoples' Hospital of Jiaozuo City · The Second People's Hospital of Pingdingshan · The second people's Hospital of Jiyuan · Xinyang Central Hospital · Yanshi People's Hospital · Yellow River Sanmenxia hospital · Zhengzhou Central Hospital · Zhengzhou First People's Hospital · Zhoukou Central Hospital · Zhumadian Central Hospital

2018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
—	NCT03406832	Jan 2018 → Jun 2019	ST-elevation myocardial infarction	The First Affiliated Hospital of Zhengzhou University	Unknown	No outcome recorded
—	NCT03406819	Jan → Dec 2018	ST-elevation myocardial infarction, strictly posterior acute myocardial infarction	The First Affiliated Hospital of Zhengzhou University	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Nitroprusside Sodium	ClinicalTrials.gov intervention name — accepted as the source's own label NCT03406832 ↗ 1 NCT03406819 ↗
Route	Other	“intracoronary infusion” NCT03406819 ↗